GLP-1 /NAD is a groundbreaking dual GLP-1 and GIP receptor agonist. Clinically proven to reduce appetite and slow gastric emptying, it helps individuals achieve up to 20% weight loss over 72 weeks . Beyond weight management, GLP-1/NAD enhances insulin sensitivity, supports blood sugar control, and may improve cardiovascular health .
SIGNIFICANT WEIGHT LOS
Achieve up to 20% reduction in body weight over 72 weeks, surpassing traditional weight loss methods.
BLOOD
SUGAR
Improves insulin sensitivity and helps regulate blood glucose levels, beneficial for individuals with type 2 diabetes.
APPETITE CONTROL
Reduces hunger and prolongs feelings of fullness, aiding in better portion control and reduced calorie intake.
SIGNIFICANT
WEIGHT LOSS
Achieve up to 20% reduction in body weight over 72 weeks, surpassing traditional weight loss methods .
BLOOD
SUGAR
Improves insulin sensitivity and helps regulate blood glucose levels, beneficial for individuals with type 2 diabetes .
APPETITE
CONTROL
Reduces hunger and prolongs feelings of fullness, aiding in better portion control and reduced calorie intake.
SIGNIFICANT WEIGHT LOSS
Achieve up to 20% reduction in body weight over 72 weeks, surpassing traditional weight loss methods .
BLOOD SUGAR
Improves insulin sensitivity and helps regulate blood glucose levels, beneficial for individuals with type 2 diabetes .
APPETITE CONTROL
Reduces hunger and prolongs feelings of fullness, aiding in better portion control and reduced calorie intake.
.jpg)
.png)